Intel-GE Innovations LLC has won U.S. Food and Drug Administration approval to market a new in-home health monitoring system, the company announced Friday.
FDA approval of the Intel Health Guide Express brings the product closer to commercial availability, which is targeted for the second quarter, said Aaron Duerksen, general manager of disease management for Intel-GE Care Innovations.
No comments:
Post a Comment